Latest Posts

ACP RELOCATING TO CHICAGO IN JUNE; POSITIONING ITSELF AS VENOUS, LYMPHATIC ADVOCACY LEADER
After 30 years in San Leandro, Calif., The American College of Phlebology (ACP) is relocating its headquarters to Chicago. The move is expected to be complete by the end of June. The new address will be 434 W. Ontario St., Suite 200, Chicago, IL, 60654. This move is one of
VARITHENA IS AN ELEGANT SOLUTION FOR C6 ULCER
At 4 months post-treatment, Tom’s wound remained closed and he stated that he was very satisfied with the treatment. By Kenneth Otah, MD, MSc, FACC Patients with venous ulcers make up over up more than 70 percent of nonhealing ulcers. By the time these patients are referred to
AMERICAN VEIN OWNERS TEACH CUTTING EDGE VEIN PROCEDURES IN CHINA
American Vein & Vascular Institute owners Gordon F. Gibbs, MD, and Erin Gibbs have returned from 10 days in China teaching Chinese doctors contemporary vascular healthcare practices. In partnership with Medtronic, Dr. and Mrs. Gibbs recently traveled to Beijing and Shanghai, teaching 50 Chinese doctors through presentations, training sessions and
BUREAUCRAT MYSTERY: CMS CANCELS EXCITE RULE TO SPEED MEDICAL DEVICE MANUFACTURING
Just when you thought the government was going to cut through its own red tape to help get medical devices to the market quicker, the U.S. Centers for Medicare & Medicaid Services (CMS) decided that it must have lost its mind. The CMS has withdrawn a proposed rule intended to
BTG OPTALYSE PE TRIAL RESULTS REINFORCE SAFETY AND EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE
BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to